| 1 |
Park JM, Lee SC, Ham C, Kim YW. Effect of probiotic supplementation on gastrointestinal motility, inflammation, motor, non-motor symptoms and mental health in Parkinson's disease: a meta-analysis of randomized controlled trials. Gut Pathog 2023;15:9. [PMID: 36879342 DOI: 10.1186/s13099-023-00536-1] [Reference Citation Analysis]
|
| 2 |
Pöltl L, Kitsera M, Raffl S, Schild S, Cosic A, Kienesberger S, Unterhauser K, Raber G, Lembacher-Fadum C, Breinbauer R, Gorkiewicz G, Sebastian C, Hoefler G, Zechner EL. Microbiota-derived genotoxin tilimycin generates colonic stem cell mutations. Cell Rep 2023;42:112199. [PMID: 36870054 DOI: 10.1016/j.celrep.2023.112199] [Reference Citation Analysis]
|
| 3 |
Purdel C, Ungurianu A, Adam-Dima I, Margină D. Exploring the potential impact of probiotic use on drug metabolism and efficacy. Biomed Pharmacother 2023;161:114468. [PMID: 36868015 DOI: 10.1016/j.biopha.2023.114468] [Reference Citation Analysis]
|
| 4 |
Zhao F, Guo Z, Kwok LY, Zhao Z, Wang K, Li Y, Sun Z, Zhao J, Zhang H. Bifidobacterium lactis Probio-M8 improves bone metabolism in patients with postmenopausal osteoporosis, possibly by modulating the gut microbiota. Eur J Nutr 2023;62:965-76. [PMID: 36334119 DOI: 10.1007/s00394-022-03042-3] [Reference Citation Analysis]
|
| 5 |
Park JM, Lee SC, Ham C, Kim YW. Effects of probiotic supplementation on gastrointestinal motility, inflammation, motor and non-motor symptoms in Parkinson's disease: a meta-analysis of randomized controlled trials.. [DOI: 10.21203/rs.3.rs-2461162/v1] [Reference Citation Analysis]
|
| 6 |
Lin CH, Lai HC, Wu MS. Gut-oriented disease modifying therapy for Parkinson's disease. J Formos Med Assoc 2023;122:9-18. [PMID: 36182642 DOI: 10.1016/j.jfma.2022.09.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Shen X, Xu L, Zhang Z, Yang Y, Li P, Ma T, Guo S, Kwok LY, Sun Z. Postbiotic gel relieves clinical symptoms of bacterial vaginitis by regulating the vaginal microbiota. Front Cell Infect Microbiol 2023;13:1114364. [PMID: 36816588 DOI: 10.3389/fcimb.2023.1114364] [Reference Citation Analysis]
|
| 8 |
Shi S, Zhang Q, Sang Y, Ge S, Wang Q, Wang R, He J. Probiotic Bifidobacterium longum BB68S Improves Cognitive Functions in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients 2022;15. [PMID: 36615708 DOI: 10.3390/nu15010051] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Zhang T, Zhang W, Feng C, Kwok LY, He Q, Sun Z. Stronger gut microbiome modulatory effects by postbiotics than probiotics in a mouse colitis model. NPJ Sci Food 2022;6:53. [PMID: 36379940 DOI: 10.1038/s41538-022-00169-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Bonnechère B, Amin N, van Duijn C. What Are the Key Gut Microbiota Involved in Neurological Diseases? A Systematic Review. Int J Mol Sci 2022;23. [PMID: 36430144 DOI: 10.3390/ijms232213665] [Reference Citation Analysis]
|
| 11 |
Li T, Chu C, Yu L, Zhai Q, Wang S, Zhao J, Zhang H, Chen W, Tian F. Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease. Nutrients 2022;14:4678. [DOI: 10.3390/nu14214678] [Reference Citation Analysis]
|
| 12 |
Varesi A, Campagnoli LIM, Fahmideh F, Pierella E, Romeo M, Ricevuti G, Nicoletta M, Chirumbolo S, Pascale A. The Interplay between Gut Microbiota and Parkinson's Disease: Implications on Diagnosis and Treatment. Int J Mol Sci 2022;23:12289. [PMID: 36293176 DOI: 10.3390/ijms232012289] [Reference Citation Analysis]
|
| 13 |
Manfready RA, Goetz CG, Keshavarzian A. Intestinal microbiota and neuroinflammation in Parkinson's disease: At the helm of the gut-brain axis. International Review of Neurobiology 2022. [DOI: 10.1016/bs.irn.2022.07.008] [Reference Citation Analysis]
|
